Website Header with Language Selector and Dropdowns

Chemical Name: Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate.

Country of Origin: India

Product Category:Heparin Impurities


Disodium 5'-Uridylate is identified by CAS No. 3387-36-8 and is chemically known as Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate.

Disodium 5'-Uridylate is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Heparin.

Page Keywords: Buy Disodium 5'-Uridylate | Purchase Disodium 5'-Uridylate | Disodium 5'-Uridylate suppliers | Disodium 5'-Uridylate manufacturers | Disodium 5'-Uridylate price | Disodium 5'-Uridylate Importer | Disodium 5'-Uridylate Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-HPR-07
CAS No: 951-77-9
Mol Wt: 227.2
Mol F: C9H13N3O4
Inv. Status: Custom Synthesis
CAT No: CL-HPR-12
CAS No: 207121-55-9
Mol Wt: 267.2 : X(18.0)
Mol F: C10H13N5O4 : X(H2O)
Inv. Status: Custom Synthesis
CAT No: CL-HPR-06
CAS No: 312693-72-4
Mol Wt: 267.2 : 18.0
Mol F: C10H13N5O4 : H2O
Inv. Status: Custom Synthesis
CAT No: CL-HPR-08
CAS No: 38313-48-3
Mol Wt: 224.2
Mol F: C10H12N2O4
Inv. Status: Custom Synthesis
CAT No: CL-HPR-09
CAS No: 52448-10-9
Mol Wt: 337.2
Mol F: C10H16N3O8P
Inv. Status: Custom Synthesis
CAT No: CL-HPR-13
CAS No: [5550-12-9]
Mol Wt: 363.2 : 2(23.0)
Mol F: C10H14N5O8P : 2(Na)
Inv. Status: Custom Synthesis
CAT No: CL-HPR-10
CAS No: 118-00-3
Mol Wt: 283.2
Mol F: C10H13N5O5
Inv. Status: Custom Synthesis
Address(India):

Plot No. A-737/2, TTC Industrial area,
MIDC, Kopar Khairne, Navi Mumbai, INDIA, 400710

           
Address(Bangladesh):

House No. - 12, Road No. - 17, Nikunja -2,
Khilkhet, Dhaka-1230, Bangladesh.

Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.